학술논문
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins.
Document Type
Article
Author
Source
Journal of Cardiovascular Pharmacology & Therapeutics; 2022, Vol. 27, p1-11, 11p
Subject
Language
ISSN
10742484
Abstract
Copyright of Journal of Cardiovascular Pharmacology & Therapeutics is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)